The Union health ministry is planning to set up an portal to regulate and plug the gaps in drug sales through all platforms, including e-pharmacies to ensure availability of right drugs that meet the quality standards, and also to curb anti-microbial resistance drugs apart from regulating online drug sales.
According to the proposal, an autonomous body will be set up to develop and maintain the e-platform on which drug- makers, stockists, wholesalers, distributors, licenced chemists and e-pharmacies have to register.
"The proposal of e-portal by the Union health ministry is completely impractical. Considering the insufficient IT infrastructure in the country, it will be difficult and difficult for most of stockists, druggists and chemists to upload the details of the sale on the e-portal within a stipulated time. We fear that this will cause drug scarcity," Jagannath Shinde, president of AIOCD said in a statement.
"Not only those doctors registered with the Medical Council of India or their respective state medical/dental councils, but also those doctors from homoeopathy, ayurveda and
unani indulge in allopathic practises and issue prescriptions.
"This is a serious problem and if the medicines are denied on such prescriptions, people in the rural areas will be deprived of medicines which can even lead to a law and order issue," Shinde warned.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
